IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 25,965 results that match your search.25,965 results
  • Expect relative fairness testing
    Novartis/Alcon is set to ask whether minority shareholders can expect a fairness opinion that considers higher bids for majority shareholdings
    January 14 2010
  • Why cov-lites won’t migrate
    Cov-lite loans were criticised during the financial crisis. But cov-lite elements to deals are being used again in the US, with their popularity set to rise throughout 2010
    January 14 2010
  • How private equity will use alternative financing
    With valuations mismatched and bank lending still slow, US private equity purchasers will turn to earn-outs and seller financing to bridge the gap in 2010
    January 14 2010
  • Flipper clauses will prevail in securitisation deals
    Flipper clauses will continue to gain popularity as a means of forcing bondholders into new agreements
    January 14 2010
  • Counterparty risk will dominate deals and regulation
    Investors are already demanding new structures on deals to mitigate counterparty default risk. Regulatory initiatives in 2010 will follow that lead
    January 14 2010
  • DLA hires in Shanghai
    DLA Piper has boosted its corporate capacity with a new partner in Shanghai. Wan Li joins the firm from Minter Ellison where he was office managing partner.
    January 12 2010
  • Orrick and Baker McKenzie on HK oil IPO
    Shengli Oil & Gas Pipe has launched its HK$1.58 billion ($204 million) initial public offering (IPO) on the Hong Kong Stock Exchange. The IPO includes a global placement under Rule 144A/Regulation S.
    January 12 2010
  • First German IPO overcomes HK listing rules
    How Schramm Holding became the first German company to list on the Hong Kong Stock Exchange
    January 12 2010
  • The disclosure dangers of dual-track offerings
    New interest in dual-track offerings for private equity exits means owners must be careful whom they disclose key financial information to
    January 12 2010
  • Senate to ignore OTC regulatory arbitrage
    Despite recent fears that the US and Europe are diverging on OTC derivatives regulation, the US Senate is unlikely to consider the prospect of regulatory arbitrage when legislating
    January 11 2010
Previous
1
...
1496
1497
1498
1499
1500
...
2596
Next